Tocilizumab and COVID-19: Timing of Administration and Efficacy

• Main Authors: Emna Abidi (Author), Wasim S. El Nekidy (Author), Eman Alefishat (Author), Nadeem Rahman (Author), Georg A. Petroianu (Author), Rania El-Lababidi (Author), Jihad Mallat (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Elevated concentrations of interleukin-6 have been demonstrated to be an important key factor in COVID-19 host immune impairment. It represents an important prognostic factor of harm associated with COVID-19 infection by stimulating a vigorous proinflammatory response, leading to the so-called "...